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We would like to thank Dr. Farrington for his important comment (1) regarding our article on disease and vaccine efficacy (2) . We are aware of the different models for the effects of a vaccine on susceptibility (3, 4) . There is some evidence that the measles vaccine indeed affords mostly "all or nothing" protection (5) . In general, we agree that the heterogeneous effect of a vaccine on susceptibility should be taken into account when the efficacy of that vaccine is evaluated. However, when only the final attack rates are known, as is the case in our paper (2), then there is no way to identify "leaky" or "all or nothing" vaccine effects or mixtures of these effects.
We are currently developing methods for estimating the heterogeneous effects of vaccines from incidence data (6, 7) . These heterogeneities result in frailty effects that are taken into account in the analysis. The new methods provide an estimate of the overall vaccine efficacy, along with estimates of the "leaky" and "all or nothing" effects and of mixtures of these effects of the vaccine.
